Phase 3 Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at least 18 years old.
- People who are able to attend scheduled check-up visits at specific points over the 12-month study period.
- People who have been diagnosed with fatty liver, confirmed by an ultrasound or MRI scan of the abdomen.
- People who have signs of liver inflammation lasting more than three months, shown by a specific liver enzyme (ALT) reading above 41 IU/L on a blood test.
Who may not be able to join:
- People who are under 18 years old.
- People who are pregnant or breastfeeding.
- People with an active viral hepatitis infection (hepatitis B or hepatitis C), as detected by a blood test.
- People who are currently taking a medication called hydroxychloroquine (HCQ) for another health condition.
- People who have a known allergy or history of a serious reaction to hydroxychloroquine (HCQ).
- People who have a condition affecting the retina at the back of the eye, known as retinal maculopathy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 88623123456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
serum ALT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.